IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Boone Capital Management LLC

Q4 2025 Holdings

Filed 2026-02-17 | 15 holdings | $318.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Medtronic PLC(MDT)SHSG5960L103$41.2M428,78912.9%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$33.3M421,23610.4%
Ionis Pharmaceuticals Inc(IONS)COM462222100$33.1M417,83310.4%
The Cigna Group(CI)COM125523100$26.5M96,4538.3%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$24.5M411,8807.7%
Neurocrine Biosciences Inc(NBIX)COM64125C109$21.5M151,8156.8%
Unitedhealth Group Inc(UNH)COM91324P102$20.4M61,7626.4%
Astrazeneca PLC(AZN)SPONSORED ADR046353108$20.2M220,2016.4%
Healthequity Inc(HQY)COM42226A107$19.5M212,8566.1%
Livanova PLC(LIVN)SHSG5509L101$17.8M288,8955.6%
Rapt Therapeutics Inc(RAPT)COM NEW75382E208$15.9M470,4565.0%
Bridgebio Pharma Inc(BBIO)COM10806X102$14.1M184,9634.4%
Kodiak Sciences Inc(KOD)COM50015M109$14.1M503,8304.4%
Tyra Biosciences Inc(TYRA)COM90240B106$10.5M398,4823.3%
Wave Life Sciences LTD(WVE)SHSY95308105$6.0M352,1441.9%